top of page
Search
resarch.PNG

​

Paper on testing the feasibility and safety of omitting routine growth factors during adjuvant breast cancer chemotherapy to avoid unnecessary toxicity and expense (April 2020).

​

Vaz-Luis et al., Avoiding peg-filgrastim (Peg-F) prophylaxis during paclitaxel (T) portion of the dose-dense (DD) doxorubicin cyclophosphamide (AC) regimen: a prospective study, Journal of Clinical Oncology, April 2020

​

​

​

c_edited.jpg
ASCO Poster 2018

​​

​

Poster titled "Avoiding peg-filgrastim (Peg-F) prophylaxis during paclitaxel (T) portion of the dosedense (DD) doxorubicin-cyclophosphamide (AC) regimen: a prospective study" presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL (June 2018).

​

​

SABCS 2019 Poster

Poster titled "Phase II Trial of GDC-0084 in combination with Trastuzumab for Patients with HER2-Positive Breast Cancer Brain Metastases (BCBM)" presented at the San Antonio Breast Cancer Symposium (SABCS) Annual Meeting in San Antonio, TX (December 2019).

Other conferences attended:

​

  • BIOMEDevice

          San Jose, CA | December 2020​

​

  • Center for Effective Global Action: Innovations in Health Data & Measurement

          San Francisco, CA | October 2020

​

  • San Antonio Breast Cancer Symposium

          San Antonio, TX | December 2018

​

  • Oncology Live State of the Science Summit in Breast Oncology

          Boston, MA | May 2018

​

  • Roche BETi NP39487 Clinical Trial Investigator Meeting

          New York, NY & Toronto, Ontario | October 2017 & 2018

​

  • Translational Breast Cancer Research Consortium Annual Meeting  

          Nashville, TN | September 2017

IMG_3585.JPG
cgph.jpg

As part of the UC Berkeley Global Health Specialty Program, I wrote two relevant policy brief proposals focused on women's health issues. These articles call to action the clinical needs of preventing postpartum hemorrhage in Chad and improving diagnostic systems for breast cancer in Argentina. Data surrounding the issue and rationale for geographic selection are discussed, followed by potential solutions and tangible recommendations for intervention.

© 2023 Lindsey Milisits

  • LinkedIn
bottom of page